{"id":"https://openalex.org/W2947062046","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.512","title":"Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.","display_name":"Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947062046","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.512","mag":"2947062046"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.512","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.512","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.512","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030303296","display_name":"Arlindo Rebelo Ferreira","orcid":"https://orcid.org/0000-0002-1567-9322","observed_orcids":["https://orcid.org/0000-0002-1567-9322"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Arlindo R. Ferreira","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025683264","display_name":"Antonio Di Meglio","orcid":"https://orcid.org/0000-0002-0233-3189","observed_orcids":["https://orcid.org/0000-0002-0233-3189"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antonio Di Meglio","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009030272","display_name":"Barbara Pistilli","orcid":"https://orcid.org/0000-0002-9184-7199","observed_orcids":["https://orcid.org/0000-0002-9184-7199"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Barbara Pistilli","raw_affiliation_strings":["Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084065716","display_name":"Arnauld S. Gbenou","orcid":"https://orcid.org/0000-0002-8614-3023","observed_orcids":["https://orcid.org/0000-0002-8614-3023"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Arnauld S. Gbenou","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107541461","display_name":"Mayssam El Mouhebb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mayssam El-Mouhebb","raw_affiliation_strings":["Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008316207","display_name":"Sibille Everhard","orcid":"https://orcid.org/0000-0002-3151-5707","observed_orcids":["https://orcid.org/0000-0002-3151-5707"]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sibille Everhard","raw_affiliation_strings":["Unicancer, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unicancer, Paris, France;","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103061358","display_name":"Charles Coutant","orcid":"https://orcid.org/0000-0003-4355-7012","observed_orcids":["https://orcid.org/0000-0003-4355-7012","https://orcid.org/0000-0003-0533-503X"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Charles Coutant","raw_affiliation_strings":["Centre Georges-Fran\u00e7ois Leclerc, Dijon, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges-Fran\u00e7ois Leclerc, Dijon, France;","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034058277","display_name":"Paul Henri Cottu","orcid":"https://orcid.org/0000-0001-6434-3932","observed_orcids":["https://orcid.org/0000-0001-6434-3932"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Paul-Henri Cottu","raw_affiliation_strings":["Institut Curie, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, Paris, France;","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112773994","display_name":"Florence Lerebours","orcid":"https://orcid.org/0000-0002-3952-4296","observed_orcids":["https://orcid.org/0000-0002-3952-4296"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Lerebours","raw_affiliation_strings":["Institut Curie, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, Paris, France;","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101788093","display_name":"Thierry Petit","orcid":"https://orcid.org/0000-0002-8746-0725","observed_orcids":["https://orcid.org/0000-0002-8746-0725","https://orcid.org/0000-0001-8368-3174","https://orcid.org/0000-0003-1968-1056"]},"institutions":[{"id":"https://openalex.org/I68947357","display_name":"Universit\u00e9 de Strasbourg","ror":"https://ror.org/00pg6eq24","country_code":"FR","type":"education","lineage":["https://openalex.org/I68947357"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thierry Petit","raw_affiliation_strings":["Paul Strauss Cancer Center and University of Strasbourg, Strasbourg, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paul Strauss Cancer Center and University of Strasbourg, Strasbourg, France;","institution_ids":["https://openalex.org/I68947357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058791215","display_name":"Florence Dalenc","orcid":"https://orcid.org/0000-0002-9854-4182","observed_orcids":["https://orcid.org/0000-0002-9854-4182"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087620","display_name":"Centre de Recherches en Canc\u00e9rologie de Toulouse","ror":"https://ror.org/003412r28","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Dalenc","raw_affiliation_strings":["Department of Medicalo Oncology, Institut Claudius Regaud, IUCT-Oncopole, CRCT, Inserm, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicalo Oncology, Institut Claudius Regaud, IUCT-Oncopole, CRCT, Inserm, Toulouse, France;","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014886244","display_name":"Philippe Rouanet","orcid":"https://orcid.org/0000-0003-0415-3269","observed_orcids":["https://orcid.org/0000-0003-0415-3269"]},"institutions":[{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Rouanet","raw_affiliation_strings":["Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut R\u00e9gional du Cancer de Montpellier, Montpellier, France;","institution_ids":["https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109394849","display_name":"Antoine Arnaud","orcid":"https://orcid.org/0000-0003-1925-4521","observed_orcids":["https://orcid.org/0000-0003-1925-4521"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antoine Arnaud","raw_affiliation_strings":["CRLC Val D'Aurelle, Montpellier, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRLC Val D'Aurelle, Montpellier, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013759812","display_name":"Anne\u2010Laure Martin","orcid":"https://orcid.org/0000-0002-9302-8576","observed_orcids":["https://orcid.org/0000-0002-9302-8576"]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne-Laure Martin","raw_affiliation_strings":["Unicancer, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unicancer, Paris, France;","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103153387","display_name":"Patricia A. Ganz","orcid":"https://orcid.org/0000-0002-1841-4143","observed_orcids":["https://orcid.org/0000-0002-1841-4143"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia A. Ganz","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann H. Partridge","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083142899","display_name":"Suzette Delaloge","orcid":"https://orcid.org/0000-0003-2106-9165","observed_orcids":["https://orcid.org/0000-0003-2106-9165"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Suzette Delaloge","raw_affiliation_strings":["Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062814767","display_name":"Stefan Michiels","orcid":"https://orcid.org/0000-0002-6963-2968","observed_orcids":["https://orcid.org/0000-0002-6963-2968"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stefan Michiels","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001814176","display_name":"Fabrice Andr\u00e9","orcid":"https://orcid.org/0000-0001-5795-8357","observed_orcids":["https://orcid.org/0000-0001-5795-8357","https://orcid.org/0000-0002-6272-6048"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabrice Andre","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103783700","display_name":"In\u00eas Maria Vaz Duarte Luis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ines Maria Vaz Duarte Luis","raw_affiliation_strings":["Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"512","last_page":"512"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13077","display_name":"Cancer-related cognitive impairment studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7870000004768372},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9620000123977661},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.7419999837875366},{"id":"https://openalex.org/keywords/menopausal-status","display_name":"menopausal status","score":0.8899999856948853},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9940000176429749},{"id":"https://openalex.org/keywords/chronic-toxicity","display_name":"chronic toxicity","score":0.6069999933242798},{"id":"https://openalex.org/keywords/breast-cancer-survivors","display_name":"breast cancer survivors","score":0.7020000219345093},{"id":"https://openalex.org/keywords/eortc-qlq-c30","display_name":"EORTC QLQ-C30","score":0.824999988079071},{"id":"https://openalex.org/keywords/eortc-qlq-br23","display_name":"EORTC QLQ-BR23","score":0.9070000052452087},{"id":"https://openalex.org/keywords/smoking","display_name":"smoking","score":0.3790000081062317},{"id":"https://openalex.org/keywords/income","display_name":"income","score":0.7020000219345093},{"id":"https://openalex.org/keywords/mastectomy","display_name":"mastectomy","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9649401903152466},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.6618897914886475},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6465778946876526},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6161171197891235},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5206541419029236},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5196641683578491},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5101495385169983},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.45770004391670227},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.43024927377700806},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.4262143075466156},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4017049968242645},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40017831325531006},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.512","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.512","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.512","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980243529","https://openalex.org/W7130714573","https://openalex.org/W4309873908","https://openalex.org/W4282555841","https://openalex.org/W4362657031","https://openalex.org/W2325910749","https://openalex.org/W4409839870","https://openalex.org/W3203851046","https://openalex.org/W4399921761","https://openalex.org/W3091977247"],"abstract_inverted_index":{"512":[0],"Background:":[1],"We":[2,34],"recently":[3],"witnessed":[4],"a":[5,56,258,307],"trend":[6],"to":[7,36,121],"de-escalate":[8],"CT":[9,41,108,159,200,243,280],"and":[10,42,92,102,125,143,166,212,297],"escalate":[11],"ET":[12,43,110,168,184,193,229,303],"in":[13,225,239],"adjuvant":[14,295],"BC":[15,64,71,263],"treatment":[16],"(tx).":[17],"However,":[18],"there":[19],"has":[20],"been":[21],"limited":[22],"prior":[23],"research":[24,308],"investigating":[25],"the":[26,38,88,222],"differential":[27,285],"impact":[28,39],"on":[29,44,282,287],"QoL":[30,45,83,187,197,266],"of":[31,40,61,70,107,127,138,254,262,279,300],"tx":[32,123,211],"classes.":[33],"aimed":[35],"test":[37],"PROs":[46],"2":[47,189,202,267],"yrs":[48,190,268],"after":[49,183,191,269],"diagnosis":[50],"(dx).":[51],"Methods:":[52],"CANTO":[53],"(NCT01993498)":[54],"is":[55,232,246,271],"multicenter":[57],"prospective":[58,260],"longitudinal":[59],"study":[60],"stage":[62,153],"I-III":[63],"pts":[65,79,139,178,301],"that":[66],"characterizes":[67],"long-term":[68],"toxicities":[69],"tx.":[72],"For":[73],"this":[74],"analysis":[75],"we":[76],"included":[77],"4262":[78],"recruited":[80],"from":[81],"2012-14.":[82],"was":[84,97,134],"extensively":[85],"evaluated":[86],"using":[87],"EORTC":[89],"QLQ":[90],"C30":[91],"BR23.":[93],"Linear":[94],"regression":[95],"modeling":[96],"performed,":[98],"adjusting":[99],"for":[100,302],"demographic":[101],"clinical":[103],"factors,":[104],"with":[105,218,234,248,274],"use":[106],"and/or":[109],"as":[111],"independent":[112],"variables.":[113],"Analyses":[114],"were":[115,140],"stratified":[116,223],"by":[117],"menopausal":[118],"status":[119],"due":[120],"different":[122],"patterns":[124],"sequelae":[126],"CT.":[128],"Results:":[129],"Median":[130],"age":[131],"at":[132,201],"dx":[133,270],"56":[135],"yrs,":[136],"63%":[137],"post":[141],"(PostM)":[142],"37%":[144],"premenopausal":[145],"(PreM),":[146],"80%":[147],"had":[148,179],"Charlson":[149],"score":[150],"0,":[151],"91%":[152],"I-II.":[154],"26%":[155],"received":[156],"mastectomy,":[157],"52%":[158],"(preM":[160,169],"68%,":[161],"postM":[162,172,226],"44%;":[163],"86%":[164],"anthracycline+taxane)":[165],"82%":[167],"89%":[170],"tamoxifen;":[171],"88%":[173],"aromatase":[174],"inhibitor).":[175],"32%":[176],"preM":[177,240],"menses":[180],"1":[181],"year":[182],"initiation.":[185],"Overall,":[186],"deteriorates":[188],"dx.":[192],"negatively":[194],"impacts":[195],"more":[196],"domains":[198],"than":[199],"yrs.":[203],"Also,":[204],"young":[205],"age,":[206],"smoking,":[207],"income,":[208],"aggressive":[209],"local":[210],"physiological":[213],"distress":[214],"are":[215],"often":[216],"associated":[217,233,247,273],"low":[219],"QoL.":[220,236,250],"In":[221,237,257],"analyses,":[224],"pts,":[227,241],"mostly":[228,242,272],"(not":[230,244],"CT)":[231],"deteriorated":[235,249],"contrast,":[238],"ET)":[245],"Table":[251],"shows":[252],"eg":[253],"associations.":[255],"Conclusions:":[256],"large":[259],"cohort":[261],"survivors,":[264],"detrimental":[265],"ET;":[275],"however,":[276],"negative":[277],"effects":[278],"persist":[281],"preM.":[283],"This":[284],"effect":[286],"QOL":[288],"should":[289,305],"be":[290,306],"considered":[291],"when":[292],"choosing":[293],"optimal":[294],"therapy":[296],"appropriate":[298],"selection":[299],"escalation":[304],"priority.":[309],"[Table:":[310],"see":[311],"text]":[312]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2019-06-07T00:00:00"}